Introducing FoamaDerm™

A novel base for better outcomes

FoamaDerm™ is a propellant-free foam, which is designed to be used as a base for diclofenac sodium. FoamaDerm™ is a water based formulation which provides a non-greasy feeling for patient after application and does not stain clothes.

Top 5 reasons to choose FoamaDerm™

1. Patient Tested

Effectiveness of 2% diclofenac in FoamaDerm™ has been tested at the University of Alberta on patients suffering from chronic pain. Click to read the article

4. Advanced Base,

Enhanced Skin Penetration

FoamaDerm™ is a nanotechnology product, developed by pharmaceutical scientists for advanced drug delivery.

2. Better Patient Compliance

Water-based, non-greasy formulation favorable by patients. Also, since low concentrations of drug is used, minimum or no or skin irritation happens. 

5. Easy Compounding

Just add diclofenac and mix; no solvents or other tools required. No cleaning required.

3. Better Drug Release Profile 

Diclofenac in FoamaDerm™ has better drug release compared to other bases. Click to read the article

Patient demographics and their treatment response to 2% diclofenac in FoamaDerm™. (Ref: adapted from BMC Res Notes 13, 285, 2020)

About Company

We truly see ourselves as your partners in providing solutions tailored to meet your patients' needs. RS Therapeutics Inc. is an Edmonton based company which is dedicated to providing advanced compounding solutions that work.

Terms and Conditions 

All right reserved.

Copyright  2020 RS Therapeutics Inc. 

  • Twitter
  • YouTube
  • Facebook